Chemotherapy-Induced Nausea and Vomiting.

Karen M Mustian, Tom V Darling, Michelle C Janelsins, Pascal Jean-Pierre, Joseph A Roscoe, Gary R Morrow
{"title":"Chemotherapy-Induced Nausea and Vomiting.","authors":"Karen M Mustian,&nbsp;Tom V Darling,&nbsp;Michelle C Janelsins,&nbsp;Pascal Jean-Pierre,&nbsp;Joseph A Roscoe,&nbsp;Gary R Morrow","doi":"10.17925/ohr.2008.04.1.19","DOIUrl":null,"url":null,"abstract":"<p><p>Despite treatment advances, nausea and vomiting, especially anticipatory nausea and vomiting, delayed nausea and vomiting and nausea alone, are still the most common, expected and feared side effects among patients receiving chemotherapy. Of the 70 to 80% of cancer patients who experience chemotherapy-induced nausea and vomiting many will delay or refuse future chemotherapy treatments and contemplate stopping all treatments because of fear of further nausea and vomiting. The purpose of this chapter is to provide an overview of the patho-psychophysiology of CINV, the recommended guidelines for standard treatment, and highlight newer targeted treatment approaches.</p>","PeriodicalId":89517,"journal":{"name":"US oncology","volume":"4 1","pages":"19-23"},"PeriodicalIF":0.0000,"publicationDate":"2008-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994039/pdf/nihms543671.pdf","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"US oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17925/ohr.2008.04.1.19","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Despite treatment advances, nausea and vomiting, especially anticipatory nausea and vomiting, delayed nausea and vomiting and nausea alone, are still the most common, expected and feared side effects among patients receiving chemotherapy. Of the 70 to 80% of cancer patients who experience chemotherapy-induced nausea and vomiting many will delay or refuse future chemotherapy treatments and contemplate stopping all treatments because of fear of further nausea and vomiting. The purpose of this chapter is to provide an overview of the patho-psychophysiology of CINV, the recommended guidelines for standard treatment, and highlight newer targeted treatment approaches.

化疗引起的恶心和呕吐。
尽管治疗进展,恶心和呕吐,特别是预期性恶心和呕吐、延迟性恶心、呕吐和单独恶心,仍然是化疗患者中最常见、最预期和最担心的副作用。在经历化疗引起的恶心和呕吐的70%至80%的癌症患者中,许多人会推迟或拒绝未来的化疗治疗,并考虑停止所有治疗,因为害怕进一步的恶心和呕吐。本章的目的是概述CINV的病理心理生理学,推荐的标准治疗指南,并强调新的靶向治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信